Chronic Glomerulonephritis
Definition
- Group of diseases with unknown etiology and unclear pathogenesis.
- Similar clinical picture and treatment
- Progressive evolution and predominant morphological changes in the glomeruli
Classification
Nephrotic syndrome- Proteinuria
- Edema
- Hypoproteinemia with dysproteinemia
- Hyperlipidemia with dyslipidemia
- Lipiduria
I. Idiopathic Nephrotic Syndrome (INS)
- Minimal change GLN
- Mesangioproliferative GLN with IgM deposits
- Focal segmental glomerulosclerosis (FSGS)
II. Membraneous GLN
III. Mesangioproliferative GLN
- With IgG deposits
- With IgA deposits
- With C3 deposits
IV. Membranoproliferative GLN/Mesangiocapillary
Etiology – most cases unclear
- Bacterial infections – beta haemolytic strep; staph, meningio, pneumo, entero
- Viral infections – flu, hep, herpes, HIV, EBV, CMV
- Fungi – candida, histoplasma capsulatum
- Parasites – plasmodium malariae, toxoplasma gondii
- Drug and chemicals – volatile hydrocarbons, solvents; serums, vaccines
Pathogenesis
- Immunocomplex
- By circulating CIC
- By ICs formed In situ
- Autoimmune
- Anti-GBM Abs, Abs against other glomerular components (podocytes, mesangial cells)
- ICs penetrate endothelium and BM > if titre is high they form dome like shapes > proliferation of mesangial cells, decrease of capillary lumen (to encompass the deposits) > decreased BF and perfusion > decreased GFR
Idiopathic Nephrotic Syndrome (INS)
- Common features
- Unclear etiology and pathogenesis
- Identical morphology – epth foot changes, mesangial proliferation, IgM deposits
- Nephrotic syndrome
- Minimal change GLN (lipoid nephrosis) – MC in children, no deposits
- Pathoanat (light microscopy)
- lack of definitive alterations in glomeruli, cellularity is normal/minimal; tubular + interstitial structures are normal
- GBM is uniform
- Light/absent mesangial proliferation
- Absence of Ig deposits
- Fusion of epth foot processes (only seen on electron microscope)
- Clinical picture
- Severe NS – mod/severe proteinuria (>2/3g/L); pronounced soft edema
- Absence of arterial HTN
- Normal renal function and serum Igs
- Pathoanat (light microscopy)
-
- Mesangioproliferative GLN with IgM deposits
- Pathoanat – more severe morphological changes
- Mesangial prolif with expanded mesangium
- Deposits of IgM, C3, fibrin
- Epithelial foot changes
- Clinical picture
- Nephrotic syndrome
- Arterial HTN, hematuria, anemia
- Pathoanat – more severe morphological changes
- Focal segmental glomerulosclerosis (hyalinosis)
- Pathoanatomy – segmental sclerosis and hyalinosis (replaces mesangial prolif)
- Epithelial foot changes
- Deposits of IgM, C3, fibrin
- Clinical picture
- Arterial HTN, hematuria
- NS
- Pts easily develop renal failure
- Pathoanatomy – segmental sclerosis and hyalinosis (replaces mesangial prolif)
Membranous GLN
- Pathology
- GBM changes – thickening, spikes
- Mesangial changes – glom sclerosis, NO prolif
- Deposits of IgG, M, A; C3, fibrin
- Clinical picture
- NS, HTN
Mesangioproliferative GLN – MC chronic GLN in adults
- Patho
- No podocyte changes or GBM changes
- Mesangial prolif and dilation
- Mesangial deposits of IgG, C3, fibrin
- Morphological variants
- With IgG and/or C3 deposits
- With IgA deposits – disease of Berger
- Lupus nephritis, alport syndrome
- Clinical pic
- NO nephrotic syndrome – proteinuria is mild <1.5g/l
- HTN, microscopic hematuria, proteinuria, no edema
- Best prognosis – 20 years without renal failure
Membranoproliferative GLN/Mesangiocapillary
- Patho
- Mesagnial and endothelial proliferation
- Mesangial interposition, duplicated GBM
- Mesangial deposits of C3 and IgG
- Clinical pic
- Nephrotic syndome, HTN, hematuria
- Early progression to RF
Diagnosis – 4 steps
- Enough clinical feature – proteinuria, edema, hematuria, HTN
- Data from history and physical exam
- Lab exam – urinalysis, serum proteins, BUN, creatinine
- Histological verification – transcutaneous renal biopsy
Treatment
- Etiological treatment – no value
- Symptomatic treatment
- Of NS – treat edema, hypoproteinemia
- Of HTN
- Others – pleural effusion, ascites etc
- Pathogenetic treatment – most important
- Drugs
- Immunosuppressive – corticosteroids, cyclophosphamide, azathioprine, cyclosporine
- Anticoags and antiplatelets – heparin, aspririn
- NSAIDs – indomethacine, ibuprofen
- Plasma separation
- Methods
- Conventional immunosuppresion
- Prednisolone [1mg/kg/d for 30 days]
- Slowly decrease by[ 5-10mg/week to reach 10-20mg/d]
- Cyclophosphamide [0.7-1mg/kg/d]
- Prednisolone [1mg/kg/d for 30 days]
- Pulse treatment
- Urbason [10-30mg/kg/d for 3 days]
- Then continue with conventional tx
- Cyclophosphamide [10-12mg/kg ONCE]
- Urbason [10-30mg/kg/d for 3 days]
- Conventional immunosuppresion
- Combinations of drugs
- Corticosteroids + anticoag
- Corticosteroids + AC + NSAIDs
- Drugs